Oxygen consumption is increased relative to work rate in patients with McArdle's disease

European Journal of Clinical Investigation

Volumn 34, Issue 11, 2004, Pages 731-737

  O'Dochartaigh, C S ^a   Ong, H Y ^a   Lovell, S M ^a   Riley, M S ^b   Patterson, V H ^a   Young, I S ^c   Nicholls, D Paul ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b BELFAST CITY HOSPITAL   (United Kingdom)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Cardiopulmonary exercise testing; Catecholamines; McArdle's disease; Myophosphorylase deficiency

Indexed keywords

CATECHOLAMINE; NORADRENALIN;

ADULT; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE TEST; FEMALE; GLYCOGEN STORAGE DISEASE TYPE 5; HEART RATE; HUMAN; LUNG VENTILATION PERFUSION RATIO; MALE; NORADRENALIN BLOOD LEVEL; OXYGEN CONSUMPTION; PHYSICAL PERFORMANCE; PRIORITY JOURNAL;

ADULT; BLOOD PRESSURE; EPINEPHRINE; EXERCISE TEST; FEMALE; GLYCOGEN STORAGE DISEASE TYPE V; HEART RATE; HUMANS; MALE; NOREPINEPHRINE; OXYGEN CONSUMPTION; RESPIRATORY FUNCTION TESTS;

EID: 8744241219     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2004.01423.x     Document Type: Article

References (46)

1. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin Sci 1951;10:13-33.
2. Mommaerts WFHM, Illingworth B, Pearson RJ, Guillory RJ, Seraydarian K. A functional disorder of muscle associated with the absence of phosphorylase. Proc Natl Acad Sci USA 1959;45:791-7.
3. Schmid R, Mahler R. Chronic progressive myopathy with myoglobinuria: demonstration of a glycogenolytic defect in the muscle, J Clin Invest 1959;38:2044-58.
4. 2 responses of patients with McArdle's disease. J Appl Physiol 1990;68:1393-8.
5. Riley M, Nicholls DP, Nugent AM, Steele IC, Bell N, Davies PM et al. Respiratory gas exchange and metabolic responses during exercise in McArdle's disease. J Appl Physiol 1993;75:745-54.
6. Larsson LE, Linderholm H, Muller R, Rinqvist T, Sornas R. Hereditary metabolic myopathy with paroxysmal myoglobinuria due to abnormal glycolysis. J Neurol Neurosurg Psychiatry 1964;27:361-80.
7. Porte D Jr, Crawford DW, Jennings DB, Aber C, McIlroy MB. Cardiovascular and metabolic responses to exercise in a patient with McArdle's syndrome. N Engl J Med 1966;275:406-12.
8. Lange Andersen K, Lund-Johansen P, Clausen G. Metabolic and circulatory responses to muscular exercise in a subject with glycogen storage disease (McArdle's disease). Scand J Lab Clin Invest 1969;24:105-13.
9. Linderholm LH, Muller R, Rinqvist T, Sornas R. Hereditary abnormal muscle metabolism with hyperkinetic circulation during exercise. Acta Med Scand 1969;185:156-66.
10. Haller RG, Lewis SF, Blomqvist CG. Hyperkinetic circulation during exercise in neuromuscular disease. Neurology 1983;33:1283-7.
11. Lewis SF, Haller RG, Cook JD, Blomqvist CG. Metabolic control of cardiac output response to exercise in McArdle's disease. J Appl Physiol 1984;57:1749-53.
12. Haller RG, Lewis SF. The pathophysiology of McArdle's disease: clues to regulation in exercise and fatigue. J Appl Physiol 1986;61:391-401.
13. Hagberg JM, Coyle EF, Carroll JE, Miller JM, Martin WH, Brooke MH. Exercise hyperventilation in patients with McArdle's disease. J Appl Physiol 1982;52:991-4.
14. Haller RG, Lewis SF. Abnormal ventilation during exercise in McArdle's syndrome: modulation by substrate availability. Neurology 1986;36:716-9.
15. Vissing J, Lewis SF, Galbo H, Haller RG. Effect of deficient muscular glycogenolysis on extramuscular fuel production in exercise. J Appl Physiol 1992;72:1773-9.
16. Blomqvist CG, Lewis SF. Interaction between local and neurohumoral cardiovascular control mechanisms during dynamic and static exercise. In: Christensen NJ, Henriksen O, Lassen N, editors. Sympathoadrenal System. Copenhagen: Munksgaard; 1986.pp. 188-202.
17. Vissing J, MacLean DA, Vissing SF, Sander M, Saltin B, Haller RG. The exercise metaboreflex is maintained in the absence of muscle acidosis: insights from muscle microdialysis in humans with McArdle's disease. J Physiol 2001;537:641-9.
18. Carroll JE, Hagberg JM, Brooke MH, Shumate JR. Bicycle ergometry and gas exchange measurements in neuromuscular diseases. Arch Neurol 1979;36:457-61.
19. Bartram C, Edwards RH, Clague J, Beynon RJ. McArdle's disease: a nonsense mutation in exon 1 of the muscle glycogen phosphorylase gene explains some but not all cases. Hum Mol Genet 1993;2:1291-3.
20. Elborn JS, Stanford CF, Nicholls DP. Reproducibility of cardiopulmonary parameters during exercise in patients with chronic cardiac failure. Eur Heart J 1990;11:75-81.
21. Buchfuhrer ML, Hansen JE, Robinson TE, Sue DY, Wasserman K, Whipp BJ. Optimizing the exercise protocol for cardiopulmonary assessment. J Appl Physiol 1983;55:1558-64.
22. Elborn JS, Riley M, Stanford CF, Nicholls DP. Anaerobic threshold in patients with chronic cardiac failure due to ischaemic heart disease. Presse Med 1994;23:367-71.
23. Hansen JE, Casaburi R, Cooper DM, Wasserman K. Oxygen uptake as related to work rate increment during cycle ergometer exercise. Eur J Appl Physiol 1988;57:140-5.
24. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R et al. Impairment of ventilatory efficiency in heart failure: prognostic impact. Circulation 2000;101:2803-9.
25. Robinson BF. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation 1967;35:1073-83.
26. Hansen JE, Sue DY, Wasserman K. Predicted values for clinical exercise testing. Am Rev Respir Dis 1984;129:S49-S55.
27. Zhang YY, Johnson MC, Chow N, Wasserman K. Effect of exercise testing protocol on parameters of aerobic function. Med Sci Sports Exerc 1991;23:625-30.
28. Steele IC, Patterson VH, Nicholls DP. A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease. J Neurol Sci 1996;136:174-7.
29. Vissing J, Haller RG. The effect of oral sucrose on exercise tolerance in patients with McArdle's disease. N Engl J Med 2003;349:2503-9.
30. Pernow BB, Havel RJ, Jennings DB. The second wind phenomenon in McArdle's syndrome. Acta Med Scand 1967;472:294-307.
31. Macdonald IA, Bennett T, Fellows IW. Catecholamines and the control of metabolism in man. Clin Sci 1985;68:613-9.
32. Rowell LB. Human Circulation: Regulation During Physical Stress. New York: Oxford University Press;1986.
33. Jehenson P, Leroy-Willig A, de Kerviler E, Merlet P, Duboc D, Syrota A. Impairment of the exercise-induced increase in muscle perfusion in McArdle's disease. Eur J Nucl Med 1995;22:1256-60.
34. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90.
35. Wasserman K, Stringer WW, Casaburi R, Zhang YY. Mechanism of the exercise hyperkalemia: an alternate hypothesis. J Appl Physiol 1997;83:631-43.
36. Lovell SL, Maguire SM, Turtle F, McDowell G, Campbell NP, Riley MS et al. Comparative physiological study of arbutamine with exercise in humans. Clin Sci 2000;98:489-94.
37. Aaron EA, Johnson BD, Seow CK, Dempsey JA. Oxygen cost of exercise hyperpnea: measurement. J Appl Physiol 1992;72:1810-7.
38. Coakley JH, Wagenmakers AJ, Edwards RH. Relationship between ammonia, heart rate, and exertion in McArdle's disease. Am J Physiol 1992;262:E167-72.
39. Vanuxem D, Delpierre S, Fauvelle E, Guillot C, Vanuxem P. Blood ammonia and ventilation at maximal exercise. Arch Physiol Biochem 1998;106:290-6.
40. Wagenmakers AJ, Coakley JH, Edwards RH. Metabolism of branched-chain amino acids and ammonia during exercise: clues from McArdle's disease. Int J Sports Med 1990;11 (Suppl. 2):S101-13.
41. Chui LA, Munsat TL. Dominant inheritance of McArdle syndrome. Arch Neurol 1976;33:636-41.
42. Tsujino S, Shanske S, DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle's disease). N Engl J Med 1993;329:241-5.
43. Manfredi G, Silvestri G, Servidei S, Ricci E, Mirabella M, Bertini E et al. Manifesting heterozygotes in McArdle's disease: clinical, morphological and biochemical studies in a family. J Neurol Sci 1993;115:91-4.
44. Berg JM, Tymoczko JL, Stryer L. Biochemistry. New York: W.H. Freeman;2002.
45. Wheeler SD, Brooke MH. Vascular insufficiency in McArdle's disease. Neurology 1983;33:249-50.
46. Nicholls DP, Campbell NPS, Stevenson HP, Patterson VH. Angina in McArdle's disease. Heart 1996;76:372-3.